Kratom (Mitragyna speciosa) is one of the most chemically complex botanicals available in the supplement market today. While many plants contain a handful of active compounds, kratom leaves harbor over 40 identified alkaloids—a remarkably diverse chemical arsenal that has drawn increasing attention from pharmacologists, chemists, and botanical researchers worldwide. Understanding these alkaloids is key to understanding what makes kratom unique as a botanical. This article provides an accessible, science-based overview of kratom’s alkaloid profile, what each major compound does in preclinical research, and why the interplay between these compounds matters.
What Are Alkaloids?
Alkaloids are a class of naturally occurring organic compounds that contain at least one nitrogen atom. Found throughout the plant kingdom, alkaloids are responsible for the active properties of many well-known plants including coffee (caffeine), tea (theanine and caffeine), cocoa (theobromine), tobacco (nicotine), and black pepper (piperine). The word “alkaloid” literally means “alkali-like,” referring to the basic (as opposed to acidic) chemical nature of these compounds.
Plants produce alkaloids as part of their natural defense mechanisms—to deter herbivores, protect against pathogens, and gain competitive advantages in their ecosystems. The fact that many plant alkaloids interact with animal and human biological systems is a consequence of the evolutionary arms race between plants and the organisms that feed on them.
Kratom’s alkaloids belong primarily to the indole and oxindole alkaloid families, which are also found in other plants in the Rubiaceae (coffee) family. This shared botanical lineage is one reason kratom and coffee are sometimes compared, despite their very different alkaloid profiles and traditional uses.
The Major Kratom Alkaloids
Mitragynine
Mitragynine is the most abundant alkaloid in kratom leaves, typically accounting for 60–66% of the total alkaloid content. First isolated in 1921 by Ellen Field and later characterized in detail by D. Zacharias and colleagues in the 1960s, mitragynine has been the subject of more scientific study than any other kratom alkaloid.
Key characteristics identified in preclinical research include:
- Receptor interactions: Mitragynine has been characterized as a partial agonist at mu-opioid receptors in laboratory studies, which is pharmacologically distinct from full agonists. It also interacts with delta-opioid, kappa-opioid, adrenergic, serotonergic, and dopaminergic receptor systems in preclinical models.
- Concentration variability: Mitragynine content in raw kratom leaf can range from approximately 1% to over 2% by dry weight, depending on growing conditions, harvest timing, leaf maturity, geographic origin, and processing methods.
- Metabolic conversion: Research has shown that mitragynine can be converted to 7-hydroxymitragynine through metabolic processes involving liver enzyme CYP3A4.
7-Hydroxymitragynine (7-OH)
7-Hydroxymitragynine is the second most well-studied kratom alkaloid, despite being present in very small quantities—typically 0.01–0.04% of dry leaf weight. Its significance comes from preclinical findings suggesting it has substantially higher binding affinity at mu-opioid receptors compared to mitragynine. For a detailed exploration of this compound, see our article: What Is 7-Hydroxymitragynine?
Paynantheine
Paynantheine is the second most abundant alkaloid in kratom leaves after mitragynine, typically comprising 8–9% of the total alkaloid content. Despite its abundance, paynantheine has received far less research attention than mitragynine or 7-OH. Preclinical studies have identified it as a smooth muscle relaxant, though its full pharmacological profile remains incompletely characterized.
Speciogynine
Speciogynine is the third most abundant alkaloid, accounting for roughly 6–7% of total alkaloid content. Like paynantheine, speciogynine has been identified as a smooth muscle relaxant in preclinical studies. The structural similarity between speciogynine and paynantheine suggests related but potentially distinct biological activities.
Speciociliatine
Speciociliatine is a diastereomer of mitragynine (a compound with the same molecular formula but a different three-dimensional arrangement of atoms). It is present at roughly 0.5–1% of total alkaloid content. While less studied than the major alkaloids, speciociliatine has been the subject of increasing research interest.
Mitraphylline
Mitraphylline is an oxindole alkaloid also found in cat’s claw (Uncaria tomentosa), a South American medicinal plant. Its presence in both kratom and cat’s claw reflects the shared Rubiaceae family lineage. Mitraphylline has been studied for various biological activities in preclinical models.
Ajmalicine (Raubasine)
Ajmalicine, also known as raubasine, is another notable kratom alkaloid. It is also found in Rauwolfia serpentina (Indian snakeroot) and Catharanthus roseus (Madagascar periwinkle). In preclinical and some clinical contexts, ajmalicine has been studied for its effects on smooth muscle and cerebral circulation.
Corynantheidine
Corynantheidine is present in smaller quantities and has been identified in preclinical studies as a mu-opioid receptor antagonist—meaning it may block rather than activate these receptors. The presence of both agonists (mitragynine) and antagonists (corynantheidine) within the same plant is part of what makes kratom’s pharmacology so complex and is thought to contribute to the overall balance of effects.
Rhynchophylline and Isorhynchophylline
Rhynchophylline and its isomer isorhynchophylline are oxindole alkaloids found in small quantities in kratom. These compounds are also found in cat’s claw and have been the subject of preclinical research exploring various biological activities.
The Entourage Effect: Why the Whole Is Greater Than the Sum
One of the most important concepts in understanding kratom alkaloids is the entourage effect—the theory that the combined action of multiple compounds produces effects that differ from those of any single compound in isolation. This concept is well-established in cannabis research but applies broadly to complex botanical preparations.
In the case of kratom, the entourage effect helps explain several observations:
- Whole-leaf versus isolated compounds: Traditional use of whole kratom leaf or leaf preparations (teas, powders) provides the full spectrum of 40+ alkaloids working in concert. Isolating individual alkaloids fundamentally changes the pharmacological picture.
- Agonist-antagonist balance: The presence of both receptor agonists (like mitragynine) and antagonists (like corynantheidine) within the same plant suggests a built-in self-modulating system. This may help explain why traditional whole-leaf kratom use has a different profile than isolated, concentrated alkaloid products.
- Strain differences: Different kratom strains (red, green, white, and various regional varieties) have different alkaloid ratios, not just different amounts of the same alkaloids. These varying ratios produce the distinct characteristics that users associate with different strains.
The entourage effect is a key reason why many kratom researchers and advocates argue that whole-leaf kratom products should be evaluated differently from isolated or synthetic kratom alkaloids. The complex interplay of multiple compounds in whole leaf represents a fundamentally different pharmacological proposition than a single isolated compound.
What Affects Alkaloid Content?
The alkaloid profile of any given kratom product is influenced by numerous factors throughout the plant’s lifecycle and the supply chain:
Growing Conditions
- Soil composition: The mineral content, pH, and organic matter of the soil directly affect alkaloid production. Volcanic soils (as found in parts of Sumatra) and alluvial soils (along river systems in Borneo) each contribute distinct characteristics.
- Climate: Temperature, humidity, rainfall patterns, and sunlight exposure all influence alkaloid synthesis in the living plant.
- Altitude: Kratom grown at different elevations may develop different alkaloid concentrations.
Harvest Factors
- Leaf maturity: Younger leaves generally have different alkaloid profiles than fully mature leaves. This is one factor behind the vein color classification system (white/young, green/mid, red/mature).
- Season: Alkaloid content can fluctuate seasonally, influenced by rainfall, temperature, and the tree’s growth cycle.
- Individual tree genetics: Just as coffee cherries from different trees produce coffee with different flavor profiles, kratom leaves from different trees can have different alkaloid compositions.
Post-Harvest Processing
- Drying method: Indoor drying, sun drying, and fermentation each alter the alkaloid profile through oxidation and other chemical processes.
- Drying duration: Extended drying periods can change alkaloid concentrations.
- Storage conditions: Exposure to light, heat, oxygen, and moisture can degrade certain alkaloids over time.
This natural variability is why third-party lab testing is so important. Without testing, there is no way to know the specific alkaloid content of any given batch. At Hudson Valley Botanicals, every batch we sell is tested and the results are published on our COAs page, so you know exactly what you are getting.
The Future of Kratom Alkaloid Research
Scientific understanding of kratom alkaloids is still in its early stages relative to well-studied pharmaceutical compounds. Active and emerging areas of research include:
- Complete alkaloid characterization: While over 40 alkaloids have been identified, many remain poorly characterized. Future research will likely reveal new details about minor alkaloids’ roles.
- Pharmacokinetic studies: Understanding how kratom alkaloids are absorbed, distributed, metabolized, and eliminated in humans is critical for building a complete scientific picture.
- Entourage effect mechanisms: Elucidating exactly how multiple kratom alkaloids interact with each other and with biological systems.
- Standardization: Developing reliable methods for standardizing kratom products based on alkaloid content.
As this research progresses, consumers will benefit from an increasingly detailed and nuanced understanding of the science behind the botanicals they use. At Hudson Valley Botanicals, we are committed to sharing accurate, up-to-date scientific information with our community. Visit our About Kratom page for more educational content, or contact us if you have questions about kratom science.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
